2011
DOI: 10.1016/j.juro.2011.03.033
|View full text |Cite
|
Sign up to set email alerts
|

A Specific Gene Expression Signature Characterizes Metastatic Potential in Clear Cell Renal Cell Carcinoma

Abstract: We determined a metastatic signature of clear cell renal cell carcinoma by microarray analysis. Our data provide the possibility of defining the metastatic potential of primary clear cell renal cell carcinoma based on a select number of genes even in a localized situation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 29 publications
1
24
0
Order By: Relevance
“…3C). Significant underexpression of NFKBIA/IKBa, an inhibitor of NF-kB, harbored in the frequently lost 14q region, was able to discriminate metastatic ccRCCs from nonmetastatic tumors in a previous study (48), suggesting deletion and subsequent underexpression of NFKBIA to be indicative of metastatic potential in ccRCCs. A recent study associated deletions and low expression of NFKBIA with resistance to treatment and worse survival in glioblastomas (49).…”
Section: Discussionmentioning
confidence: 73%
“…3C). Significant underexpression of NFKBIA/IKBa, an inhibitor of NF-kB, harbored in the frequently lost 14q region, was able to discriminate metastatic ccRCCs from nonmetastatic tumors in a previous study (48), suggesting deletion and subsequent underexpression of NFKBIA to be indicative of metastatic potential in ccRCCs. A recent study associated deletions and low expression of NFKBIA with resistance to treatment and worse survival in glioblastomas (49).…”
Section: Discussionmentioning
confidence: 73%
“…Biomarker role. Microarray analysis of renal cell carcinoma showed an over-expression of MMP-16 in metastatic primary tumors, suggesting that MMP-16 is one of the potential biomarker for metastatic clear cell renal cell carcinoma (Sanjmyatav et al, 2011).…”
Section: Neoplastic Diseasesmentioning
confidence: 99%
“…MMP16 not only activates pro-MMP2 by proteolytic cleavage, but is also known to degrade ECM proteins, especially basement membrane components, which facilitates cancer cell migration and tumor spreading (36). Although MMP16 protein has not been previously analyzed in endometrial tumors, its overexpression has been associated with malignant behavior and poor prognosis in numerous human malignancies, including colorectal cancer, gastric cancer, hepatocellular carcinoma, melanoma and renal cell carcinoma (36)(37)(38)(39)(40)(41). For instance, MMP16 has been reported as a β-catenin target gene in human gastric cancer, which induction is relevant for the Wnt-mediated invasion and metastasis in gastric cancer cells (38).…”
Section: Discussionmentioning
confidence: 99%